The CIHR - Institute of Cancer Research & CAPO Research Excellence Award in Psychosocial Oncology
2025 Research Excellence Winner
Josée Savard, Ph.D., is a professor of psychology at Université Laval (Québec, Canada) and researcher at the CHU de Québec-Université Laval Research Center and Université Laval Cancer Research Center and a clinical psychologist specialized in cognitive-behavioural therapy and psycho-oncology. She completed in 1996 her Ph.D. in psychology at Université Laval and then completed a post-doctoral fellowship in psycho-oncology at the Fox Chase Cancer Center in Philadelphia. Her research projects are mainly centered on the psychological aspects of cancer and the efficacy and accessibility of cognitive-behavioural interventions for improving patients’ quality of life. More specifically, she is recognized as an international leader in the study of cancer-related insomnia. In 2020, she co-edited the Handbook of Sleep Disorders in Medical Conditions (Elsevier), which received the PROSE award of the Association of American Publishers for the best handbook in medicine and clinical science. She is also the first author of a treatment manual for fear of cancer recurrence (Treating fear of cancer recurrence with group cognitive-behavioural therapy: A step-by-step guide; Springer) that was published in 2022. She has received many awards and was elected fellow of the Canadian Psychological Association (CPA) in 2015 and fellow of the Canadian Association of Cognitive and Behavioural Therapies in 2022.
Submissions are now closed.
The purpose of this award is to recognize an individual who, in the opinion of the Awards Committee and the Board of Directors Association, has made a significant research contribution to Psychosocial Oncology. This award will follow a nomination and selection process as outlined in the Award Terms of Reference.
Eligibility
- Eligibility is limited to members in good standing of CAPO (for at least one year prior to the nomination).
- Award recipients must register and attend the annual CAPO conference (in person or virtually) in order to be eligible.
Application Criteria
- The purpose of this award is to recognize an individual who, in the opinion of the Awards Committee and the Board of Directors of the Association, has made a significant research contribution to psychosocial oncology.
- The award will be presented at the annual CAPO conference by the Chair of the Awards Committee or an Institute designate.
- The winner(s) agree to have their name(s) released as winners of the award and to be featured on CHIR-ICR's various communication channels (e.g., website, social media, newsletter).
Anticipated Timeline
- November 7, 2024: Launch of call for applications
- February 14, 2025: Submissions due
- Awarded at CAPO conference
Award
- Recognition award and reimbursement for travel expenses to the CAPO annual conference up to $1000
Application Process
- Submit application below
CLICK HERE TO SUBMIT FOR CIHR RESEARCH EXCELLENCE AWARD
2024 Award Receipient for Research excellence: Dr. Sylvie Lambert
| Past Winners
|
Sylvie Lambert, RN, PhD is Associate Professor and Associate Director of Research at the Ingram School of Nursing, McGill University; and Scientist at the St. Mary’s Research Centre, Montreal. Sylvie is also the recipient of a CIHR Canada Research Chair (Tier 2) in self-care and illness self-management support interventions. In this position, the objectives of her research programs include: 1) developing and evaluating low-cost self-care and illness self-management interventions that are sustainable to enhance translation in practice, 2) implementing real-world patient-reported outcome (PRO) and caregiver-reported outcome (CRO) screening programs, 3) adapting evidence-based self-management interventions to the needs of patients from a culturally and linguistically diverse background and their caregivers, and 4) using advanced psychometric approaches for improving the precision and efficiency of outcome evaluations. One of Dr Lambert’s key study is TEMPO, which stands for a tailored web-based self-management and physical activity program for men with prostate cancer and their caregivers. A pan-canadian trial of TEMPO was recently funded by CIHR. She is also leading e-IMPAQc for the electronic implementation of patient-reported outcomes across the cancer continuum in Quebec. Sylvie has received national and international recognition of her work in the form of several awards and prizes.The CIHR - Institute of Cancer Research & CAPO Early Career Investigator in Psychosocial Oncology Award
2025 Early Career Investigator Winner
Dr. Laura Struik, PhD, RN – Assistant Professor at the School of Nursing, UBC Okanagan
My program of research is focused on youth health promotion and cancer prevention, particularly as it relates to tobacco and nicotine product use. The research I conduct is underpinned by youth engagement and strong national and international partnerships to push the boundaries of traditional health promotion approaches and incorporate youth cultures, youth voices, and digital technologies in behavior change interventions, ultimately leveraging the potential impact of such interventions for the prevention of cancer.
Submissions are now closed.
The CIHR - Institute of Cancer Research & CAPO Early Career Investigator Award in Psychosocial Oncology honours a new investigator for outstanding contributions to research in the field of psychosocial oncology. Candidates must be within seven years of completing their postgraduate, fellowship or equivalent specialist training (defined as a PhD or MD or equivalent).
This award will follow a nomination and selection process as outlined in the Award Terms of Reference.
Eligibility
- The nominee must be within seven years of completing their postgraduate, fellowship, or equivalent specialist training (defined as a PhD or MD or equivalent).
- Eligibility is limited to members in good standing of CAPO (for at least one year prior to the nomination).
- Award recipients must register and attend the annual CAPO conference (in person or virtually) in order to be eligible.
Application Criteria
- The purpose of this award is to recognize a new investigator for outstanding contributions to research in the field of psychosocial oncology.
- The award will be presented at the annual CAPO conference by the Chair of the Awards Committee or an Institute designate.
- The winner(s) agree to have their name(s) released as winners of the award and to be featured on CHIR-ICR's various communication channels (e.g., website, social media, newsletter).
Anticipated Timeline
- November 7, 2024: Launch of call for applications
- February 14, 2025: Submissions due
- Awarded at CAPO conference
Award
- Recognition award and reimbursement for travel expenses to the CAPO annual conference up to $1000
Application Process
- Submit application below
CLICK HERE TO SUBMIT FOR CIHR EARLY CAREER INVESTIGATOR AWARD
2024 Early Career Investigator Award Recipient: Dr. Gilla Shapiro
Over the past decade, Dr. Shapiro’s research has focused on cancer prevention, health decision making, and supporting diverse patients with cancer. Dr. Shapiro’s research incorporates a health equity lens, and she investigates factors that contribute to making important health decisions (such as HPV vaccination), developing evidence-based interventions in diverse patients with cancer, improving health services, and enhancing patients’ experience. Her scholarly work has resulted in over 60 publications as well as several book chapters, commissioned reports, op-ed pieces, and patient education booklets. Dr. Shapiro’s work has been recognized through awards including CIHR’s Institute of Health Sciences and Policy Research Rising Star Award, the Royal Society of Canada’s Alice Wilson Award, and the CPA’s Health Psychology and Behavioural Medicine Section's Early Career Award. Her research has been funded by the Canadian Institutes of Health Research, Canadian Immunization Research Network, and the Canadian Cancer Society. | Past Winners
|
Dr. Gilla Shapiro is a Psychologist and Clinician Scientist at the Department of Supportive Care, Princess Margaret Cancer Centre, and an Assistant Professor (Status-Only) at the Department of Psychiatry, Institute of Medical Science, and the Dalla Lana School of Public Health, University of Toronto. The Canadian Association of 189 Queen Street East, Suite 1 
 | Sitemap |
|
